Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The vagus nerve is a nerve that controls many bodily functions, including stomach function. Investigators hope that electrically stimulating the nerve around the external ear will also stimulate the internal vagus nerve. If it does, then investigators hope that this may lead to additional treatment options for patients with nausea and vomiting and disordered stomach function.
The overall purpose of the ABVN Phase 2 grant is to expand on previous work evaluating the effects of noninvasive stimulation on vagal nerve function. This will be accomplished through several independent, but related, studies. In this study, investigators will evaluate the effect of percutaneous electrical field stimulation on the vagus nerve in healthy subjects.
[This study was originally described in NCT06491758, however a separate record has been created to more accurately reflect the independence of the individual studies supported by the ABVN 2 grant.]
Full description
Healthy volunteer subjects will be recruited for this project, which will be completed at a single study visit.
When participants arrive, they will be fitted with:
the PENFS device; placed behind the left ear using steri strips after the skin is cleansed using Sureprep (a medicinal wipe similar to an alcohol wipe)
Multi-electrode array (MEA); which consists of 30 small, plastic electrocardiogram (ECG) like electrodes that stick to the skin and will be placed on either side of the neck area over the vagus nerve.
ECG electrodes, placed on:
Participants will lie on their back and undergo a 20-minute baseline recording of vagal nerve activity. During the baseline recording, no current is delivered to the ear. Following the baseline recording, participants will undergo their randomly assigned experimental condition (either active stimulation delivered via the PENFS device, or no stimulation) for 20 minutes, After the experimental recording is completed, the device will be removed and participants will continue to lie on their back for 20 minutes of recovery.
Continuous vagal nerve, ECG, and EGG recordings are obtained during the baseline, experimental, and recovery rest periods.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria healthy volunteers
Exclusion Criteria healthy volunteers:
Primary purpose
Allocation
Interventional model
Masking
23 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal